Bio-Techne (TECH) EBIT Margin (2016 - 2025)
Historic EBIT Margin for Bio-Techne (TECH) over the last 17 years, with Q4 2025 value amounting to 18.41%.
- Bio-Techne's EBIT Margin rose 24400.0% to 18.41% in Q4 2025 from the same period last year, while for Dec 2025 it was 9.62%, marking a year-over-year decrease of 71200.0%. This contributed to the annual value of 8.38% for FY2025, which is 94500.0% down from last year.
- Latest data reveals that Bio-Techne reported EBIT Margin of 18.41% as of Q4 2025, which was up 24400.0% from 16.63% recorded in Q3 2025.
- In the past 5 years, Bio-Techne's EBIT Margin registered a high of 2815.85% during Q3 2022, and its lowest value of 7.53% during Q2 2025.
- Over the past 5 years, Bio-Techne's median EBIT Margin value was 22.62% (recorded in 2021), while the average stood at 160.08%.
- In the last 5 years, Bio-Techne's EBIT Margin soared by 27913200bps in 2022 and then tumbled by -27956800bps in 2023.
- Quarter analysis of 5 years shows Bio-Techne's EBIT Margin stood at 23.15% in 2021, then rose by 8bps to 25.0% in 2022, then tumbled by -44bps to 13.94% in 2023, then grew by 15bps to 15.96% in 2024, then rose by 15bps to 18.41% in 2025.
- Its EBIT Margin stands at 18.41% for Q4 2025, versus 16.63% for Q3 2025 and 7.53% for Q2 2025.